A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer
Clinical trial NCT04158700 · WITHDRAWN
Trial details
- NCT number
- NCT04158700
- Sponsor
- Eli Lilly and Company
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-05
- Primary completion
- 2023-05-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.